Literature DB >> 17031091

Pride and prejudice: inflammatory bowel disease models and drug development.

D K Podolsky.   

Abstract

Entities:  

Year:  2000        PMID： 17031091     DOI： 10.1097/00001574-200007000-00001

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN： 0267-1379            Impact factor:   3.287


× No keyword cloud information.
  6 in total

1.  Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.

Authors:  David L Suskind; Ghassan Wahbeh; Tyler Burpee; Morty Cohen; Dennis Christie; Wendy Weber
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-03       Impact factor: 2.839

2.  Antimicrobial peptide CC34 attenuates intestinal inflammation via downregulation of the NF-κB signaling pathway.

Authors:  Liqiang Dong; Huan Yang; Zhao Wang; Ning Jiang; Aizhong Zhang
Journal:  3 Biotech       Date:  2021-08-04       Impact factor: 2.893

3.  Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis.

Authors:  Chi Chen; Yatrik M Shah; Keiichirou Morimura; Kristopher W Krausz; Makoto Miyazaki; Terrilyn A Richardson; Edward T Morgan; James M Ntambi; Jeffrey R Idle; Frank J Gonzalez
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

4.  Intestinal Anti-Inflammatory Activity of Baccharis dracunculifolia in the Trinitrobenzenesulphonic Acid Model of Rat Colitis.

Authors:  Sílvia Helena Cestari; Jairo Kennup Bastos; Luiz Claudio Di Stasi
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

5.  Impact of phytosterols on liver and distal colon metabolome in experimental murine colitis model: an explorative study.

Authors:  Nunzia Iaccarino; Jussara Amato; Bruno Pagano; Anna Di Porzio; Matteo Micucci; Luca Bolelli; Rita Aldini; Ettore Novellino; Roberta Budriesi; Antonio Randazzo
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  Posttraumatic growth and death anxiety in caregivers of cancer patients: PHOENIX study

Authors:  Ali Alkan; Elif Berna Köksoy; Ebru Karci; Asli Alkan; Eduardo Bruera; Filiz Çay Şenler
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.